• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[腹膜炎患者中毒性肝病时门静脉血的选择性解毒作用]

[Selective detoxication of the portal vein blood in toxic hepatopathy in patients with peritonitis].

作者信息

Vatazin A V, Kruglov E E, Fomin A M, Suslov V P, Koshelev R V, Astakhov P V

出版信息

Anesteziol Reanimatol. 2002 Mar-Apr(2):73-6.

PMID:12227007
Abstract

Selective detoxication of the blood from the portal vein was carried out in 31 patients with peritonitis complicated by multiple organ dysfunction including toxic hepatopathy. Selective extracorporeal detoxication of the blood from the portal vein possesses notable regional hemodynamic advantages in comparison with other variants of vascular approaches and essentially improves the transhepatic bloodflow. The authors emphasize that bifiltration cascade exchange portoplasmapheresis is a method of choice in severe toxic hepatopathy in patients with peritonitis. They recommend alternating bifiltration cascade exchange portoplasmapheresis with portohemofiltration in patients with toxic hepatonephropathy.

摘要

对31例并发包括中毒性肝病在内的多器官功能障碍的腹膜炎患者进行了门静脉血液的选择性解毒。与其他血管途径变体相比,门静脉血液的选择性体外解毒具有显著的局部血流动力学优势,并能从根本上改善肝内血流。作者强调,双滤过级联交换门静脉血浆置换术是腹膜炎患者严重中毒性肝病的首选方法。他们建议对中毒性肝肾疾病患者交替进行双滤过级联交换门静脉血浆置换术和门静脉血液滤过。

相似文献

1
[Selective detoxication of the portal vein blood in toxic hepatopathy in patients with peritonitis].[腹膜炎患者中毒性肝病时门静脉血的选择性解毒作用]
Anesteziol Reanimatol. 2002 Mar-Apr(2):73-6.
2
[Extracorporeal detoxication in the treatment of peritonitis complicated with multiple organ insufficiency].
Khirurgiia (Mosk). 1994 Jul(7):19-23.
3
[Extracorporeal detoxication in combined therapy of pancreonecrosis].
Anesteziol Reanimatol. 2002 Mar-Apr(2):66-70.
4
[Choice of a method of extracorporeal detoxication in pyogenic peritonitis].[化脓性腹膜炎体外解毒方法的选择]
Anesteziol Reanimatol. 1989 May-Jun(3):25-8.
5
[Hemofiltration in the terminal phase of diffuse suppurative peritonitis].[弥漫性化脓性腹膜炎终末期的血液滤过]
Sov Med. 1990(8):26-9.
6
[Criteria for the choice of the extracorporeal detoxication method in patients with postoperative renal failure].[术后肾衰竭患者体外解毒方法的选择标准]
Anesteziol Reanimatol. 1995 Jul-Aug(4):38-41.
7
[Several aspects of optimization of hemofiltration in patients with peritonitis during the multiorgan failure stage].[多器官功能衰竭期腹膜炎患者血液滤过优化的几个方面]
Anesteziol Reanimatol. 1993 May-Jun(3):43-6.
8
[Myocardial reserve during filtration detoxification in patients with suppurative peritonitis].[化脓性腹膜炎患者滤过解毒过程中的心肌储备]
Sov Med. 1991(9):8-11.
9
[Hemodynamics and oxygen transport in patients with surgical sepsis during hemofiltration].[血液滤过期间外科脓毒症患者的血流动力学与氧输送]
Anesteziol Reanimatol. 1998 Nov-Dec(6):58-62.
10
[Low-flow membrane oxygenation of blood in patients with diffuse purulent peritonitis].[弥漫性化脓性腹膜炎患者的低流量血液膜氧合]
Anesteziol Reanimatol. 1997 May-Jun(3):45-9.